The prevalence of respiratory and chronic obstructive pulmonary disease (COPD) are the main factors driving the rise in ...

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Nasal Polyps Can Cause Breathing Difficulties. Nasal polyps can make it hard to breathe out of your nose, forcing you to breathe out of your mouth. Mouth breathing may not seem ...

Risk of respiratory disease is greatly heightened for people with bipolar disorder but we are missing opportunities to intervene to improve lung health.

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

Shyamali Dharmage grew up in rural Sri Lanka and was inspired to become a doctor after watching the impact of the local ...

According to a new comprehensive report from The Insight Partners, the global pulmonary drug delivery system market is ...

A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in dementia risk, which is unlikely to outweigh its clinical benefits.

--Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Phase 3 trial, AERIFY-1, evaluating the investigational use of itepekimab in adults who were former smokers with inadequately ...